I have been on hold on ISIS for a long time and the price action- volatile -but really going nowhere has borne me out.
After listening to yesterdays conference I am slightly more optimistic.
There is really nothing out there that really does a good job raising HDL. Niacin raises it slightly but has a lot of side effects. Supposedly Pfizer has a product to be release -but I think it just targets HDL. Any ORAL drug which lowers total Cholesterol,lowers LDL, lowers triglycerides AND raises HDL has the potential to be a blockbuster!
I think what is weighing ISIS down is the past hype and misleading statements from management-(i.e. ELAN and Hepasense,etc.)
ANY positive, meaningful PHase 2,3 results for an oral drug would swing me to buy more ..time will tell.